MMP9 and Stroke: We hypothesise that MEK/ERK inhibition might represent a way to prevent stroke-induced pathology because it targets several transcriptional mechanisms activated by cerebral ischemia, such as receptor upregulation, which causes enhanced contractility, and MMP-9 and TIMP1 activation, which affect the function of the BBB.